You are here

Xoma

Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer

BioSpace

Mon, 08/28/23 - 11:39 am

pancreatic cancer

Agenus sells cut of Incyte, Merck milestone streams

Fierce Biotech

Fri, 09/21/18 - 09:55 am

The 3 Best Biotech Stocks of 2017

Motley Fool

Sun, 12/17/17 - 10:28 am

Novartis returns to the discount aisle, buys Xoma’s failed PhIII drug for $31M

Endpoints

Fri, 08/25/17 - 09:53 am

cardiovascular disease

5 BioPharma Movers That Cannot Be Ignored

24/7 Wall St

Sat, 11/7/15 - 11:38 am

Valeant Pharmaceuticals

Novartis inks a string of deals to widen its immuno-oncology arsenal

Fierce Biotech

Wed, 10/21/15 - 09:07 pm

immuno-oncology

Admune Therapeutics

Xoma enters exclusive license agreement with Novartis

Marketwatch

Thu, 10/1/15 - 09:40 am

10 Worst NASDAQ Biotech Stocks in the Third Quarter

TheStreet.com

Wed, 09/30/15 - 07:51 pm

Celldex Therapeutics

Arena Pharmaceuticals

Raptor Pharmaceutical

Decimated by clinical failure, Xoma turns to plan B

Fierce Biotech

Sat, 08/8/15 - 01:17 pm

clinical trials

endocrine disorders

Already with $1 billion in losses, Xoma plummets with late-stage drug failure

Bizjournals.com

Sat, 07/25/15 - 09:42 am

Behcet's uveitis

Xoma Is a Biotech Zombie in Need of a Kill Shot to the Head

TheStreet.com

Wed, 07/22/15 - 12:08 pm

3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double

Motley Fool

Thu, 07/16/15 - 02:27 pm

Threshold Pharmaceuticals

3 Little-Known Biotech Stocks I'm Keeping an Eye On

Motley Fool

Sun, 03/8/15 - 10:16 am

3 Biotech Stocks With Upcoming Data That Could Be Huge

24/7 Wall St

Thu, 01/22/15 - 09:33 am

Ocular Therapeutix

This Week in Biotech: Put It in Print

Motley Fool

Sun, 03/9/14 - 01:31 pm

Rigel Pharmaceuticals

Sangamo BioSciences

NewLink Genetics

Xoma to stop testing drug as arthritis treatment

Yahoo/Reuters

Tue, 03/4/14 - 10:23 pm

Keep a Close Watch on Insys and XOMA Today

Motley Fool

Fri, 12/13/13 - 09:28 am

INSYS Therapeutics

XOMA completes enrollment in Phase 2 POC Gevokizumab trial

Yahoo/Fly on the Wall

Mon, 07/22/13 - 11:28 am

Symplmed Wins Rights from XOMA

Yahoo/Zacks

Sat, 07/6/13 - 11:59 am

Symplmed Pharmaceuticals

Pages